News | Infection Update

NEWS

First malaria saliva test identifies malaria parasites

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Progress against malaria stalls

28 February, 2019

Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and...

Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and...

Can India eliminate TB by 2025?

25 January, 2019

India accounts for 27% of the estimated 10 million tuberculosis (TB) cases worldwide, and 26% of the 6.4 million new cases of TB reported in 2017 – making it one...

India accounts for 27% of the estimated 10 million tuberculosis (TB) cases worldwide, and 26% of the 6.4 million new cases of TB reported in 2017 – making it one...

Global spread of drug-resistant superbug in hospitals

05 December, 2018

Researchers at the University of Melbourne uncovered three multidrug-resistant lineages of Staphylococcus epidermidis that have evolved within the hospital environment and spread globally. The Gram-positive, catalase-negative, and coagulase-negative S. epidermidis...

Researchers at the University of Melbourne uncovered three multidrug-resistant lineages of Staphylococcus epidermidis that have evolved within the hospital environment and spread globally. The Gram-positive, catalase-negative, and coagulase-negative S. epidermidis...

First new single-dose malaria drug in 60 years

05 November, 2018

The wait is over for a new drug to counter Plasmodium vivax malaria relapse. The United States Food and Drug Administration (FDA) has approved, under Priority Review, a 300 mg...

The wait is over for a new drug to counter Plasmodium vivax malaria relapse. The United States Food and Drug Administration (FDA) has approved, under Priority Review, a 300 mg...

New biomarkers for hypervirulent Klebsiella pneumoniae causing life-threatening complications in healthy individuals

26 October, 2018

A team of researchers led by Professor Thomas Russo from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences have discovered several biomarkers that can accurately identify the...

A team of researchers led by Professor Thomas Russo from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences have discovered several biomarkers that can accurately identify the...

Paraguay attains malaria-free status

25 September, 2018

The World Health Organization (WHO) certified Paraguay malaria-free on 11 June 2018, making it the first country in the Americas since Cuba in 1973, and the first among the E-2020...

The World Health Organization (WHO) certified Paraguay malaria-free on 11 June 2018, making it the first country in the Americas since Cuba in 1973, and the first among the E-2020...

More than 100 persons infected with E. coli O157:H7 in the United State

An outbreak of Escherichia coli O157:H7 linked to romaine lettuce from the Yuma growing region in Arizona has spread to 35 states in the United States, bringing the total cases...

An outbreak of Escherichia coli O157:H7 linked to romaine lettuce from the Yuma growing region in Arizona has spread to 35 states in the United States, bringing the total cases...

E-cigarette vapour may increase risk for pneumonia

The use of electronic cigarettes (e-cigarettes) or ‘vaping’ has been marketed as a safer alternative to tobacco cigarette smoking and as a potential smoking cessation tool. However, recent findings published...

The use of electronic cigarettes (e-cigarettes) or ‘vaping’ has been marketed as a safer alternative to tobacco cigarette smoking and as a potential smoking cessation tool. However, recent findings published...

Second Case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Reported in Malaysia

The National IHR Focal Point of Malaysia reported a case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on 2 January 2018.1 The patient was a 55-year-old male residing in Malaysia who...

The National IHR Focal Point of Malaysia reported a case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on 2 January 2018.1 The patient was a 55-year-old male residing in Malaysia who...

POPULAR ARTICLES